CURRENT CANCER DRUG TARGETS

Journal Title

CURRENT CANCER DRUG TARGETS

CURR CANCER DRUG TAR

ISSN / eISSN

1568-0096 / 1873-5576

Aims and Scope

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Subject Area

ONCOLOGY

CiteScore

5.60 View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Oncology	Q2	#142/366
Medicine - Pharmacology	Q2	#125/301
Medicine - Drug Discovery	Q2	#71/156
Medicine - Cancer Research	Q3	#112/214

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
ONCOLOGY - SCIE	Q3

H-index

85

Country/Area of Publication

NETHERLANDS

Publisher

Bentham Science Publishers B.V.

Publication Frequency

Bimonthly

Year Publication Started

2001

Annual Article Volume

68

Open Access

NO

Contact

BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR